Genomic aberrations in plasma cell leukemia shown by interphase fluorescence in situ hybridization

被引:34
作者
Chang, H
Sloan, S
Li, D
Patterson, B
机构
[1] Univ Toronto, Princess Margaret Hosp, Univ Hlth Network, Dept Lab Hematol,Dept Lab Med & Pathobiol, Toronto, ON M5G 2M9, Canada
[2] Univ Toronto, Princess Margaret Hosp, Univ Hlth Network, Div Med Oncol & Hematol, Toronto, ON M5G 2M9, Canada
关键词
D O I
10.1016/j.cancergencyto.2004.05.004
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
A combination of cytoplasmic immunofluorescence to detect the immunoglobulin light chain and an interphase fluorescence in situ hybridization technique was used to study the recurrent genetic abnormalities in 14 patients with plasma cell leukemia (PCL). Of the 14 patients studied, 5 had primary and 9 secondary PCL. Chromosomal abnormalities were detected in all 14 patients (100%). Deletions of 13q14 were detected in 11 (78%) cases and deletions of 17p13.1 (TP53) in 6 (43%) cases. Translocations (11;14), (4;14), and (14;16) were found in 5 (35%), 2 (14%), and 1 (7%) cases, respectively. Except for an association between t(4;14) and 13q14 deletions, no association was identified among the genetic abnormalities. Our study revealed that recurrent genetic changes are more frequent in PCL than in multiple myeloma. The frequent TP53 deletions may represent a marker of genetic instability giving rise to an increased propensity for myeloma cells to emigrate from the bone marrow environment and enter leukemic phase. (C) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:150 / 153
页数:4
相关论文
共 25 条
[21]   p53, the cellular gatekeeper for growth and division [J].
Levine, AJ .
CELL, 1997, 88 (03) :323-331
[22]   Recurrent 14q32 translocations determine the prognosis of multiple myeloma, especially in patients receiving intensive chemotherapy [J].
Moreau, P ;
Facon, T ;
Leleu, X ;
Morineau, N ;
Huyghe, P ;
Harousseau, JL ;
Bataille, R ;
Avet-Loiseau, H .
BLOOD, 2002, 100 (05) :1579-1583
[23]   PLASMA-CELL LEUKEMIA - AN EVALUATION OF RESPONSE TO THERAPY [J].
NOEL, P ;
KYLE, RA .
AMERICAN JOURNAL OF MEDICINE, 1987, 83 (06) :1062-1068
[24]  
UESHIMA Y, 1983, CANCER RES, V43, P905
[25]   Deletion of 13q14 remains an independent adverse prognostic variable in multiple myeloma despite its frequent detection by interphase fluorescence in situ hybridization [J].
Zojer, N ;
Königsberg, R ;
Ackermann, J ;
Fritz, E ;
Dallinger, S ;
Krömer, E ;
Kaufmann, H ;
Riedl, L ;
Gisslinger, H ;
Schreiber, S ;
Heinz, R ;
Ludwig, H ;
Huber, H ;
Drach, J .
BLOOD, 2000, 95 (06) :1925-1930